CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Coronary Angiography after Cardiac Arrest without ST-Segment Elevation Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents 2-Year Clinical Outcomes: From the BIONICS and NIREUS Trials A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability Safety and feasibility of robotic percutaneous coronary intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study 2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update: A Guideline From the American Heart Association Qualitative and Mixed Methods Provide Unique Contributions to Outcomes Research

GuidelineJanuary 2019

JOURNAL:J Am Coll Cardiol. Article Link

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

CT January, LS Wann, H Calkins et al. Keywords: Anticoagulation Management; Arrhythmias and Clinical EP; Heart Failure and Cardiomyopathies; Invasive Cardiovascular Angiography and Intervention; Prevention; Valvular Heart Disease; Anticoagulation Management and Atrial Fibrillation; Implantable Devices; SCD/Ventricular Arrhythmias; Atrial Fibrillation/Supraventricular Arrhythmias; Novel Agents; Acute Heart Failure; Interventions and Structural Heart Disease

FULL TEXT PDF